Advertisement
YOU ARE HERE: LAT HomeCollections

IN BRIEF / PHARMACEUTICALS

VaxGen settles with U.S. over canceled contract

April 06, 2007|From Bloomberg News

VaxGen Inc., which cut half its workforce after losing a contract to make anthrax vaccine, said it was settling with the U.S. government for $11 million.

The agreement also releases the U.S. Health and Human Services Department and Brisbane, Calif.-based VaxGen of all liabilities related to contracts to develop anthrax vaccine, the company said.

Advertisement
Los Angeles Times Articles
|
|
|